<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1068</ReferenceId>
        <DateLastUpdated>2018-03-26-07:00</DateLastUpdated>
        <Article>
            <PubmedId>12467569</PubmedId>
            <Abstract>Although the biological properties of staphylococcal enterotoxin A (SEA) have been well characterized, structural insights into the interaction between SEA and major histocompatibilty complex (MHC) class II have only been obtained by modeling. Here, the crystal structure of the D227A variant of SEA in complex with human MHC class II has been determined by X-ray crystallography. SEA(D227A) exclusively binds with its N-terminal domain to the alpha chain of HLA-DR1. The ability of one SEA molecule to crosslink two MHC molecules was modeled. It shows that this SEA molecule cannot interact with the T cell receptor (TCR) while a second SEA molecule interacts with MHC. Because of its relatively low toxicity, the D227A variant of SEA is used in tumor therapy.</Abstract>
            <ArticleYear>2002</ArticleYear>
            <ArticlePages>1619-26</ArticlePages>
            <ArticleTitle>Crystal structure of a SEA variant in complex with MHC class II reveals the ability of SEA to crosslink MHC molecules.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Petersson</LastName>
                    <ForeName>Karin</ForeName>
                </Author>
                <Author>
                    <LastName>Thunnissen</LastName>
                    <ForeName>Marjolein</ForeName>
                </Author>
                <Author>
                    <LastName>Forsberg</LastName>
                    <ForeName>Göran</ForeName>
                </Author>
                <Author>
                    <LastName>Walse</LastName>
                    <ForeName>Björn</ForeName>
                </Author>
            </Authors>
            <Affiliations>Molecular Biophysics, Centre for Chemistry and Chemical Engineering, Lund University, P.O. Box 124, S-221 00 Lund, Sweden.</Affiliations>
            <ArticleChemicalList>Enterotoxins;Histocompatibility Antigens Class II;Receptors, Antigen, T-Cell;Recombinant Proteins;enterotoxin A, Staphylococcal</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Crystallography, X-Ray; Enterotoxins(chemistry); Histocompatibility Antigens Class II(chemistry); Lymphocyte Activation; Models, Molecular; Molecular Sequence Data; Protein Conformation; Receptors, Antigen, T-Cell(chemistry); Recombinant Proteins(chemistry)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>10</Volume>
                <Issue>12</Issue>
                <Title>Structure (London, England)</Title>
                <Issn>0969-2126</Issn>
                <MedlineTa>Structure</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>HA (306-318)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>PKYVKQNTLKLAT</LinearSequence>
                        <StartingPosition>306</StartingPosition>
                        <EndingPosition>318</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>0704243A</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11320</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Text P. 1620</LocationOfData>
                <EpitopeId>48237</EpitopeId>
                <ReferenceStartingPosition>306</ReferenceStartingPosition>
                <ReferenceEndingPosition>318</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1, Figures 1, 2, 3 and PDB 1LO5</LocationOfData>
                        <MhcBindingId>1484197</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>175</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3.2</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The crystal structure contains the MHC/epitope complex bound to the superantigen (SAG) staphylococcal enterotoxin type A variant D227A (SEA-D227A). SAG PDB chain is D. D227 -&gt; A227 mutation in SAG reduces the binding affinity of the SAG to human MHC class II molecules more than 1000-fold. SAG binds HLA-DR1 outside the peptide groove and does not contact the peptide.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1LO5</ComplexPdbId>
                            <MhcChain1PdbChain>A</MhcChain1PdbChain>
                            <MhcChain2PdbChain>B</MhcChain2PdbChain>
                            <EpitopePdbChain>C</EpitopePdbChain>
                            <EpitopeResidues>C: P306, K307, Y308, V309, K310, Q311, N312, T313, L314, K315, L316, A317, T318;</EpitopeResidues>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>The SAG molecule binds to the MHC molecule through interactions between its N-terminal β barrel and the MHC α-chain. The interacting MHC area is outside of the epitope binding groove and as such, the SAG does not make any contacts with the epitope. The binding of the SAG to the MHC/epitope complex does not cause any structural changes to the MHC molecule. The interactions between MHC molecule and peptide are not discussed in the paper.</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>C: P306, K307, Y308, V309, K310, Q311, N312, T313, L314, K315, L316, A317, T318;</EpitopeResidues>
                                <EpitopeResiduesInteractingWithMhc>C: ;</EpitopeResiduesInteractingWithMhc>
                                <MhcResiduesInteractingWithEpitope>A: ; B: ;</MhcResiduesInteractingWithEpitope>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResiduesInteractingWithMhc>C: P306, K307, Y308, V309, K310, Q311, N312, T313, L314, K315, L316, A317</EpitopeResiduesInteractingWithMhc>
                                <MhcResiduesInteractingWithEpitope>A: Q9, E11, I31, F32, W43, F51, A52, S53, F54, G58, N62, V65, N69, I72, M73, R76; B: W9, L11, F13, Y47, P56, D57, Y60, W61, L67, Q70, R71, Y78, H81, N82, V85, G86, F89</MhcResiduesInteractingWithEpitope>
                                <ContactAreaForEpitope>1294.8</ContactAreaForEpitope>
                                <ContactAreaForMhc>943.4</ContactAreaForMhc>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

